In different clinicopathologic subsets, the impact of vessel diameter on survival in the whole section cohort was significant only in ER/PR + subsets, breast cancers with lymph node metastases, and Lum B/HER2-molecular subtype. This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.